A phase I, dose-escalation study of the novel Polo-like...

A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

Patrick Schöffski, Ahmad Awada, Herlinde Dumez, Thierry Gil, Sylvie Bartholomeus, Pascal Wolter, Martine Taton, Holger Fritsch, Patricia Glomb, Gerd Munzert
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
48
Year:
2012
Language:
english
Pages:
187
DOI:
10.1016/j.ejca.2011.11.001
File:
PDF, 245 KB
english, 2012
Conversion to is in progress
Conversion to is failed